Erratum: Effect of combined patient decision aid and patient navigation vs usual care for colorectal cancer screening in a vulnerable patient population: A randomized clinical trial (JAMA Internal Medicine (2017) DOI: 10.1001/jamainternmed.2017.1294);Effect of combined patient decision aid and patient navigation vs usual care for colorectal cancer screening in a vulnerable patient population: A randomized clinical trial

JAMA Internal Medicine

Volumn 177, Issue 7, 2017, Pages 967-974

  Reuland, Daniel S ^a,b   Brenner, Alison T ^a,b   Hoffman, Richard ^c,d,e   McWilliams, Andrew ^f   Rhyne, Robert L ^e,g   Getrich, Christina ^e,h   Tapp, Hazel ^f   Weaver, Mark A ^b,i   Callan, Danelle ^g   Cubillos, Laura ^a   Urquieta De Hernandez, Brisa ^f   Pignone, Michael P ^a,b,j  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f LEVINE CANCER INSTITUTE   (United States)

^g UNIVERSITY OF NEW MEXICO   (United States)

^h UNIVERSITY OF MARYLAND   (United States)

ⁱ University of North Carolina at Chapel Hill   (United States)

^j UNIVERSITY OF TEXAS AT AUSTIN   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; CANCER RISK; CANCER SCREENING; CLINICAL DECISION SUPPORT SYSTEM; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; CONTROLLED STUDY; FEMALE; HISPANIC; HOUSEHOLD INCOME; HUMAN; INTESTINE OBSTRUCTION; LITERACY; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICALLY UNINSURED; NEW MEXICO; NORTH CAROLINA; OCCULT BLOOD TEST; PATIENT CARE; PATIENT DECISION MAKING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VULNERABLE POPULATION; AFRICAN AMERICAN; COLORECTAL NEOPLASMS; DECISION MAKING; DECISION SUPPORT SYSTEM; EARLY CANCER DIAGNOSIS; ETHNOLOGY; MEDICAL RECORD; MIDDLE AGED; OCCULT BLOOD; PRIMARY HEALTH CARE; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

AFRICAN AMERICANS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MEDICAL RECORDS, PROBLEM-ORIENTED; MIDDLE AGED; NEW MEXICO; NORTH CAROLINA; OCCULT BLOOD; PATIENT NAVIGATION; PRIMARY HEALTH CARE; VULNERABLE POPULATIONS;

EID: 85024497198     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2017.3162     Document Type: Erratum

References (63)

1. Siegel RL, Miller KD, Jamal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29.
2. American Cancer Society. Cancer Facts & Figures 2016. Atlanta, GA: American Cancer Society; 2016.
3. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
4. Bibbins-Domingo K, Grossman DC, Curry SJ, et al; US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315 (23):2564-2575.
5. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104(3):739-750.
6. Bouwmeester W, Zuithoff NP, Mallett S, et al. Reporting andmethods in clinical prediction research: a systematic review. PLoS Med. 2012;9(5):1-12.
7. Meester RG, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121(13):2281-2285.
8. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659-669.
9. JosephDA, King JB, MillerJW, Richardson LC; Centers for Disease Control and Prevention (CDC). Prevalenceofcolorectalcancerscreeningamongadults: Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Suppl. 2012;61(2)(suppl):51-56.
10. Klabunde CN, Cronin KA, Breen N,Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1611-1621.
11. Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21(6):895-904.
12. Liss DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med. 2014;46(3):228-236.
13. Diaz JA, Roberts MB, Goldman RE,Weitzen S, Eaton CB. Effect of language on colorectal cancer screening among Latinos and non-Latinos. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2169-2173.
14. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2013. Atlanta, GA: American Cancery Society; 2013.
15. Klabunde CN, Ballard-Barbash R, White MC, Thompson T, Plescia M, King SC; Centers for Disease Control and Prevention (CDC). Cancer screening: United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(3):41-45.
16. Holden DJ, Jonas DE, Porterfield DSDS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668-676.
17. Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46(9)(suppl 1):S10-S16.
18. Hawley ST,McQueenA, Bartholomew LK, et al. Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer. 2012;118(10):2726-2734.
19. Ransohoff DF, Sox HC. Clinical practice guidelines for colorectal cancer screening: new recommendations and new challenges. JAMA. 2016;315(23):2529-2531.
20. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575-582.
21. Volk RJ, Linder SK, Lopez-OlivoMA, et al. Patient decision aids for colorectal cancer screening: a systematic review and meta-analysis. Am J Prev Med. 2016;51(5):779-791.
22. Jandorf L, Braschi C, Ernstoff E, et al. Culturally targeted patient navigation for increasing African Americans' adherence to screening colonoscopy: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2013;22(9):1577-1587.
23. Paskett ED, Harrop JP,Wells KJ. Patient navigation: an update on the state of the science. CA Cancer J Clin. 2011;61(4):237-249.
24. Leone LA, Reuland DS, Lewis CL, et al. Reach, usage, and effectiveness of a Medicaid patient navigator intervention to increase colorectal cancer screening, Cape Fear, North Carolina, 2011. Prev Chronic Dis. 2013;10:E82.
25. Percac-Lima S, Ashburner JM, Zai AH, et al. Patient navigation for comprehensive cancer screening in high-risk patients using a population-based health information technology system: a randomized clinical trial. JAMA Intern Med. 2016;176(7):930-937.
26. Percac-Lima S, Grant RW, Green AR, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211-217.
27. Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171(10):906-912.
28. Percac-Lima S, Aldrich LS, Gamba GB, Bearse AM, Atlas SJ. Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. J Gen Intern Med. 2010;25(11):1198-1204.
29. Lasser KE, Murillo J, Medlin E, et al. A multilevel intervention to promote colorectal cancer screening among community health center patients: results of a pilot study. BMC FamPract. 2009;10:37.
30. Atlas SJ, Zai AH, Ashburner JM, et al. Non-visit-based cancer screening using a novel population management system. J AmBoard Fam Med. 2014;27(4):474-485.
31. Ali-Faisal SF, Colella TJ, Medina-Jaudes N, Benz Scott L. The effectiveness of patient navigation to improve healthcare utilization outcomes: ameta-analysis of randomized controlled trials [published online October 14, 2016]. Patient Educ Couns. 2017;100(3):436-448. doi:10.1016/j.pec.2016.10.014
32. Brenner AT, Getrich CM, Pignone M, et al. Comparing the effect of a decision aid plus patient navigation with usual care on colorectal cancer screening completion in vulnerable populations: study protocol for a randomized controlled trial. Trials. 2014;15(1):275.
33. Brenner AT, Hoffman R, McWilliams A, et al. Colorectal cancer screening in vulnerable patients: promoting informed and shared decisions. Am J Prev Med. 2016;51(4):454-462.
34. Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening: a randomized, controlled trial. Ann Intern Med. 2000;133(10):761-769.
35. Pignone M, Winquist A, Schild LA, et al. Effectiveness of a patient and practice-level colorectal cancer screening intervention in health plan members: the CHOICE trial. Cancer. 2011;117 (15):3352-3362.
36. Miller DP Jr, Spangler JG, Case LD, Goff DC Jr, Singh S, Pignone MP. Effectiveness of a web-based colorectal cancer screening patient decision aid: a randomized controlled trial in a mixed-literacy population. Am J Prev Med. 2011;40(6):608-615.
37. Ko LK, Reuland D, JollesM, Clay R, Pignone M. Cultural and linguistic adaptation of a multimedia colorectal cancer screening decision aid for Spanish-speaking Latinos. J Health Commun. 2014; 19(2):192-209.
38. Reuland DS, Ko LK, Fernandez A, Braswell LC, Pignone M. Testing a Spanish-language colorectal cancer screening decision aid in Latinos with limited English proficiency: results from a pre-post trial and four month follow-up survey. BMC Med Inform Decis Mak. 2012;12:53.
39. Chew LD, Griffin JM, Partin MR, et al. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med. 2008;23(5):561-566.
40. Born W, Engelman K, Greiner KA, et al. Colorectal cancer screening, perceived discrimination, and low-income and trust in doctors: a survey of minority patients. BMC Public Health. 2009;9:363.
41. Brenner AT, Callan D, Espaillat M, et al. Effect of a colorectal cancer screening decision aid on decision making outcomes in a low-income, majority Latino patient population. Paper presented at: 38th Annual Society for General Internal Medicine Conference. April 22-25, 2015; Toronto, ON, Canada.
42. Brenner AT, Ko LK, Janz N, Gupta S, Inadomi J. Race/ethnicity and primary language: health beliefs about colorectal cancer screening in a diverse, low-income population. J Health Care Poor Underserved. 2015;26(3):824-838.
43. Clemans-Cope L, Kenney G. Low income parents' reports of communication problems with health care providers: effects of language and insurance. Public Health Rep. 2007;122(2):206-216.
44. Green AR, Peters-Lewis A, Percac-Lima S, et al. Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med. 2008;23(6): 834-840.
45. Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: ameta-analysis. Ann Intern Med. 2002;136(9):641-651.
46. Klabunde CN, Lanier D, Breslau ES, et al. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med. 2007;22(8):1195-1205.
47. Lustria ML, Cortese J, Noar SM, Glueckauf RL. Computer-tailored health interventions delivered over the web: review and analysis of key components. Patient Educ Couns. 2009;74(2):156-173.
48. Lewis CL, Brenner AT, Griffith JM, Pignone MP. The uptake and effect of a mailed multi-modal colon cancer screening intervention: a pilot controlled trial. Implement Sci. 2008;3:32.
49. Lewis CL, Brenner AT, Griffith JM, Moore CG, Pignone MP. Two controlled trials to determine the effectiveness of a mailed intervention to increase colon cancer screening. N C Med J. 2012;73(2):93-98.
50. Miller KM, Brenner A, Griffith JM, Pignone MP, Lewis CL. Promoting decision aid use in primary care using a staff member for delivery. Patient Educ Couns. 2012;86(2):189-194.
51. Cronan TA, Devos-Comby L, Villalta I, Gallagher R. Ethnic differences in colorectal cancer screening. J Psychosoc Oncol. 2008;26(2):63-86.
52. Ferrer RR, Ramirez M, Beckman LJ, Danao LL, Ashing-Giwa KT. The impact of cultural characteristics on colorectal cancer screening adherence among Filipinos in the United States: a pilot study. Psychooncology. 2011;20(8):862-870.
53. Jo AM, Maxwell AE,Wong WK, Bastani R. Colorectal cancer screening among underserved Korean Americans in Los Angeles County. J Immigr Minor Health. 2008;10(2):119-126.
54. Shokar NK, Carlson CA,Weller SC. Factors associated with racial/ethnic differences in colorectal cancer screening. J AmBoard Fam Med. 2008;21(5):414-426.
55. Yepes-Rios M, Reimann JOF, Talavera AC, Ruiz de Esparza A, Talavera GA. Colorectal cancer screening amongMexican Americans at a community clinic. Am J Prev Med. 2006;30(3): 204-210.
56. Østbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann FamMed. 2005;3(3):209-214.
57. Yarnall KS, Pollak KI, Østbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4):635-641.
58. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50 (3):217-226.
59. Bensink ME, Ramsey SD, Battaglia T, et al; Patient Navigation Research Program. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program. Cancer. 2014;120(4):570-578.
60. Liss DT, French DD, Buchanan DR, et al. Outreach for annual colorectal cancer screening: a budget impact analysis for community health centers. Am J Prev Med. 2016;50(2):e54-e61.
61. Liang PS, Wheat CL, Abhat A, et al. Adherence to competing strategies for colorectal cancer screening over 3 years. Am J Gastroenterol. 2016;111 (1):105-114.
62. Baker DW, Brown T, Buchanan DR, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1235-1241.
63. Gupta S, Halm EA, Rockey DC, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013; 173(18):1725-1732.